MedicalResearch.com Interview with:
Dr. Ali Abbara
Imperial College London, United Kingdom
Dr. Abbara: What are the main findings of the study?
MedicalResearch: We found that a novel blood test for kisspeptin was able to identify asymptomatic pregnant women who were at increased risk of subsequent miscarriage. Blood kisspeptin performed better than the more commonly measured pregnancy hormone BHCG in identifying women at increased risk of miscarriage.